ProstACT Update: TARGET Study Ethics Approval
Go back to ProstACT Update: TARGET Study Ethics Approval| TRANS-LUX CORPORATION (NASDAQ: TLX) | Delayed: 10.87 +0.32 (3.03%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.55 | 52 Week High | $2.18 | |||
| Open | $10.80 | 52 Week Low | $0.30 | |||
| Day High | $10.88 | P/E | N/A | |||
| Day Low | $10.79 | EPS | $-3.32 | |||
| Volume | 144,199 | |||||



